These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7692372)

  • 41. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene.
    Mangues R; Seidman I; Pellicer A; Gordon JW
    Oncogene; 1990 Oct; 5(10):1491-7. PubMed ID: 2174525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
    Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J
    Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of a negative feedback loop involving pea3 and cyclin d2 is required for pea3-induced migration in transformed mammary epithelial cells.
    Ladam F; Damour I; Dumont P; Kherrouche Z; de Launoit Y; Tulasne D; Chotteau-Lelievre A
    Mol Cancer Res; 2013 Nov; 11(11):1412-24. PubMed ID: 23989931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
    Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
    Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the mammary hyperplasia, dysplasia and neoplasia induced in athymic female adult mice by polyomavirus.
    Haslam SZ; Wirth JJ; Counterman LJ; Fluck MM
    Oncogene; 1992 Jul; 7(7):1295-303. PubMed ID: 1320244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
    Campbell MJ; Wollish WS; Lobo M; Esserman LJ
    In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation-dependent expression of provirus-activated int-1 oncogene in clonal cell lines derived from a mouse mammary tumor.
    Schuuring E; van der Leede BJ; Willems R; Daams H; van der Valk M; van de Vijver M; van Leeuwen F; Sonnenberg A; Nusse R
    Oncogene; 1990 Apr; 5(4):459-65. PubMed ID: 2326076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
    Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
    Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
    Bojovic B; Crowe DL
    Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
    Waghorne C; Kerbel RS; Breitman ML
    Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant rat strains.
    Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1991 Oct; 51(20):5649-54. PubMed ID: 1913683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
    Guy CT; Cardiff RD; Muller WJ
    Mol Cell Biol; 1992 Mar; 12(3):954-61. PubMed ID: 1312220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
    Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P
    Cell; 1988 Jul; 54(1):105-15. PubMed ID: 2898299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
    Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous and induced metastasis of naturally occurring tumors in mice: analysis of cell shedding into the blood.
    Price JE; Carr D; Tarin D
    J Natl Cancer Inst; 1984 Dec; 73(6):1319-26. PubMed ID: 6096621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.
    Baker R; Kent CV; Silbermann RA; Hassell JA; Young LJ; Howe LR
    PLoS One; 2010 Jan; 5(1):e8854. PubMed ID: 20107508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.
    Moody SE; Sarkisian CJ; Hahn KT; Gunther EJ; Pickup S; Dugan KD; Innocent N; Cardiff RD; Schnall MD; Chodosh LA
    Cancer Cell; 2002 Dec; 2(6):451-61. PubMed ID: 12498714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Transcription factors of the PEA3 group in mammary cancer].
    Monté D; Baert JL; Laget MP; Defossez PA; Coutte L; Pelczar H; Angeli I; Dewitte F; Stéhelin D; De Launoit Y
    Ann Endocrinol (Paris); 1995; 56(5):547-51. PubMed ID: 8597501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA.
    Sfondrini L; Besusso D; Rumio C; Rodolfo M; Ménard S; Balsari A
    FASEB J; 2002 Nov; 16(13):1749-54. PubMed ID: 12409317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.